摘要
目的 观察静脉用人免疫球蛋白治疗重症甲型流感患儿的临床疗效.方法 回顾性总结本院2009年8月至2012年12月确诊的24例重症甲型流感患儿病例,随机分为治疗组（12例）和对照组（12例）,对照组予抗感染、抗病毒、雾化吸入等常规治疗,治疗组加于静脉用人免疫球蛋白治疗,对两组患儿疗效进行对照分析.结果 治疗组经治疗后,疗效明显优于对照组,两者比较,差异有统计学意义（P＜0.05）.结论 静脉用人免疫球蛋白治疗儿童甲型流感患儿有显著疗效,值得临床应用推广.
Objective To observe the clinical effect of intravenous human immunoglobulin in treatment of severe H 1N 1 influenza in children.Methods 24 children with severe H1N1 influenza from August 2009 to December 2012 were randomly divided into treatment group （12 cases） and control group （12 cases）,the control group only received routine treatment with such as anti infection,antiviral,atomizing inhalation,and so on.The treatment group used intravenous human immunoglobulin.The curative effects of two groups were compared and analyzed.Results After treatment,the curative effect of the treatment group was obviously better than that of the control group,the difference between the two group was statistically significant （P〈0.05）.Conclusion There is significant effect of intravenous human immunoglobulin therapy in severe H1N1 influenza in children,worthy of clinical application.
出处
《国际医药卫生导报》
2013年第14期2171-2173,共3页
International Medicine and Health Guidance News
关键词
静脉用人免疫球蛋白
重症甲型流感
Intravenous human immunoglobulin
Severe H 1N 1 influenza
